Brazilian MAPA bans Phibro's virginiamycin and bacitracin growth promoters; 180-day transition

PHIBRO ANIMAL HEALTH CORP

MAPA Ordinance 1617 prohibits import, manufacture, marketing and use of antimicrobial feed additives including virginiamycin and bacitracin for growth promotion.
Transition period of 180 days from April 27, 2026; products can still be sold under current labels during that time.
Phibro expects new therapeutic registrations for virginiamycin in cattle and broilers during transition; bacitracin already has therapeutic claims.
Company expects limited impact on fiscal year 2026 results; also launching PhibroVet digital prescription platform.
Additional details to be provided on May 7, 2026 earnings call.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.